# Exenatide Once Weekly for Smoking Cessation

> **NCT02975297** · PHASE1,PHASE2 · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 84 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** Exenatide
- **DRUG:** NRT
- **BEHAVIORAL:** Counseling
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02975297
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2020-01-03
- **Final completion:** 2020-01-03
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2021-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02975297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02975297, "Exenatide Once Weekly for Smoking Cessation". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT02975297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*